Profile
BLPH VRTX REGN VRNA ARGX ALNY
Company Name Bellerophon Therapeutics, Inc. Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Verona Pharma plc argenx SE Alnylam Pharmaceuticals, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $146.79K $122.53B $81.42B $72.68B $51.58B $43.35B
Employees 0.02K 6.10K 15.16K 0.21K 1.60K 2.23K
CEO Craig R. Jalbert CIRA Reshma Kewalramani Leonard S. Schleifer David S. Zaccardelli Timothy Van Hauwermeiren Yvonne L. Greenstreet
Ratings
BLPH VRTX REGN VRNA ARGX ALNY
Quant Rating Score 2 4 4 1 4 3
Quant Rating Sell Buy Buy Strong Sell Buy Neutral
Trading
BLPH VRTX REGN VRNA ARGX ALNY
Last Close $0.012 $434.02 $704.31 $106.91 $929.61 $460.54
High 52 $0.06 $513.76 $788 $106.91 $929.61 $491.09
Low 52 $0.01 $366.54 $482.92 $37.86 $532.27 $224.58
Price vs. 52 Week High -80 % -15.52 % -10.62 % 0 % 0 % -6.22 %
Price vs. 52 Week Low 20 % 18.41 % 45.84 % 182.38 % 74.65 % 105.07 %
Total Return
BLPH VRTX REGN VRNA ARGX ALNY
1 Month Return 0 % 4.13 % 21.84 % 0 % 10.19 % -4.39 %
3 Month Return 0 % 11.32 % 22.74 % 1.06 % 40.57 % 0.8 %
6 Month Return 0 % -1.06 % 18.51 % 49.92 % 64.35 % 61.42 %
9 Month Return 0 % -6.08 % 3.57 % 66.4 % 45.48 % 84.22 %
YTD Return 0 % 7.78 % -1.13 % 130.21 % 51.16 % 95.72 %
1 Year Return -67.57 % -3.12 % -5.41 % 180.68 % 61.8 % 96.59 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
BLPH VRTX REGN VRNA ARGX ALNY
Dividend Yield Percentage (TTM) - - 0.45 % - - -
Dividend Paid and Capex Coverage Ration (TTM) - 9.76 % 3.92 % -147.93 % 65.28 % 5.97 %
Dividend Per Share (TTM) - - 3.52 % - - -
Payout Ratio (TTM) - - 8.22 % - - -
Profitability
BLPH VRTX REGN VRNA ARGX ALNY
Gross Profit Margin TTM - 86.28 % 86.27 % 95.15 % 65.82 % 83.99 %
Return on Assets TTM -249.92 % 14.78 % 11.11 % -11.01 % 15.06 % 0.9 %
Return on Equity TTM -164.21 % 21.81 % 14.83 % -30.05 % 18.96 % 26.13 %
Return on Capital Employed TTM -883.35 % 19.59 % 10.3 % -8.31 % 5.04 % 8.03 %
Net Income Per EBT TTM 89.14 % 82.61 % 86.12 % 111.64 % 237.3 % -136.38 %
EBT Per Ebit TTM 99.39 % 111.4 % 146.19 % 130.36 % 147.38 % -12.07 %
EBIT Per Revenue TTM - 34.06 % 24.95 % -25.86 % 13.47 % 8.25 %
Cash Flow To Debt Ratio TTM -8753.69 % 202.64 % 184 % -29.66 % 932.29 % 9.59 %
Receivables Turnover TTM - 6.02 2.5 1.93 1.91 3.33
Payables Turnover TTM 0.05 0.4 2.1 2.37 0.9 4.37
Inventory Turnover TTM - 0.99 0.62 0.94 2.26 6.82
Fixed Asset Turnover TTM - 388.59 % 280.11 % 6536.22 % 5009.77 % 463.12 %
Asset Turnover TTM - 47.15 % 35.36 % 29.27 % 31.97 % 66.16 %
Operating Cash Flow Per Share TTM -1.86 14.55 48.39 -0.85 5.67 2.02
Free Cash Flow Per Share TTM -1.86 13.06 39.66 -0.85 5.58 1.68
Cash Per Share TTM 76.74 % 2459.7 % 8362.68 % 511.43 % 5536.58 % 2072.79 %
Operating Cash Flow Sales Ratio TTM - 31.71 % 34.71 % -43.23 % 17.54 % 8.28 %
Free Cash Flow Operating Cash Flow Ratio TTM 100 % 89.76 % 81.96 % 100.75 % 98.47 % 83.26 %
Cash Flow Coverage Ratios TTM -8753.69 % 202.64 % 184 % -29.66 % 932.29 % 9.59 %
Price To Free Cash Flows Ratio TTM -0.01 36.72 19.95 -995.27 129.37 195.85
Price To Operating Cash Flows Ratio TTM -0.01 32.86 16.2 -126.33 146.05 162.25
Price Cash Flow Ratio TTM -0.01 32.86 16.2 -126.33 146.05 162.25
Income Statement (TTM)
BLPH VRTX REGN VRNA ARGX ALNY
Revenue $0B $12B $14.34B $0.03B $2.19B $3.71B
Gross Profit $-0B $10.35B $12.24B $0.03B $1.96B $3.04B
Gross Profit Ratio 0% 86.24% 85.35% 93.89% 89.62% 81.77%
EBITDA $-0.02B $4.69B $5.82B $-0.12B $0.11B $0.56B
Net Income $-0.02B $3.95B $4.5B $-0.14B $0.83B $0.31B
EPS Diluted -2.08 15.32 41.48 -1.73 12.78 2.33
Balance Sheet (MRQ)
BLPH VRTX REGN VRNA ARGX ALNY
Long Term Debt $0B $3.69B $2.71B $0.12B $0.03B $2.7B
Total Liabilities $0.01B $6.98B $9.3B $0.27B $0.7B $4.18B
Total Equity $0B $18.67B $31.26B $0.2B $5.5B $0.79B
Total Investments $0B $5.71B $15.75B $0.02B $1.93B $1.25B
Total Debt $0B $3.69B $2.71B $0.12B $0.04B $2.97B
Total Assets $0.01B $25.64B $40.56B $0.47B $6.2B $4.97B
Cash Flow Statement (TTM)
BLPH VRTX REGN VRNA ARGX ALNY
Net Income $-0.02B $3.95B $4.5B $-0.17B $0.83B $0.31B
Inventory $0B $-0.52B $-0.28B $-0.01B $-0.1B $0.01B
Dividends Paid $0B $0B $-0.37B $0B $0B $0B
Operating Cash Flow $-0.02B $3.63B $4.98B $-0.12B $-0.08B $0.52B
Capital Expenditure $0B $-0.44B $-0.9B $-0B $-0.07B $-0.06B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 24.69
AARD Aardvark Therapeutics, Inc. Common Stock 12.14
ABCL AbCellera Biologics Inc. 3.111
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.005
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 2.505
ABPWW 0.0131
ABSI Absci Corporation 2.545
ABUS Arbutus Biopharma Corporation 3.99
ABVC ABVC BioPharma, Inc. 1.67
ABVX Abivax SA American Depositary Shares 124.925
ACAD ACADIA Pharmaceuticals Inc. 22.04
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 6.84
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 4.205
ACIU AC Immune SA 2.98
ETFs With Exposure to BLPH
Ticker ETF Name Weight Percentage Price
IWC iShares Micro-Cap ETF 0.0011 166.14
DFAT Dimensional U.S. Targeted Value ETF 0.00000009 66.295
DFAC Dimensional U.S. Core Equity 2 ETF 0.00000017 40.775
Unlock